Among all patients studied, 2.6% nodal positivity and 97.8% three-year recurrence-free survival (RFS) was observed in those ...
Study results were recently shared at the Society of Surgical Oncology (SSO) 2026 Annual Meeting in Phoenix. NCCN Cutaneous ...
Mutation found in high-altitude animals may help repair myelin damage and support new treatments for neurological disorders ...
Appropriate use of immune checkpoint inhibitors and immunotherapy differs in adults with unresectable, metastatic cutaneous ...
10hon MSN
AI’s finest hour: Tech executive uses ChatGPT to create cancer vaccine that saved his dog’s life
A tech executive utilized artificial intelligence and genomic analysis to develop a personalized experimental cancer vaccine for his dog, Rosie. This innovative approach, combining AI, genomics, and ...
Study results were recently shared at the Society of Surgical Oncology (SSO) 2026 Annual Meeting in Phoenix. NCCN Cutaneous Melanoma Guidelines recommend avoiding a sentinel lymph node (SLN) biopsy (S ...
Short kings, rejoice: Your height may come with a hidden advantage. Being tall has its perks, from reaching the top shelf to ...
The South Jersey biotech also secured a $22 million ARPA-H grant and additional investment to advance its research on therapies targeting aging.
There was a time before cell phones and free long distance when an out-of-state phone call meant something. So, when my ...
Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL ® gene silencing technology to eliminate cancer.
Better mRNA release inside cells boosts vaccine and gene editing performance, enabled by redesigned lipid molecules that grip ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results